Table of contents
- Latest Slimquick Lawsuit Updates
- February 17, 2026: Defendants Served in Class Action
- February 4, 2026: Class Action Filed in Federal Court
- August 1, 2016: DILIN Study Attributes Six Liver Injury Cases to SlimQuick
- What Is SlimQuick?
- Who May Be Affected?
- Reported Injuries or Damages
- Evidence to Preserve
- Filing Deadlines
- Frequently Asked Questions
- Is There a SlimQuick Class Action Lawsuit?
- What Does the Research Say About SlimQuick and Liver Injury?
- What Claims Does the SlimQuick Lawsuit Make About Advertising?
- What Is the HLA-B*35:01 Link to SlimQuick Liver Injury?
SlimQuick weight-loss supplements face a proposed class action over ads that call them safe and effective. The case is Nelson v. Platinum US Distribution, Inc. It was filed on February 4, 2026, in the Southern District of California.
Medical studies separately link SlimQuick products to rare cases of liver injury. A 2016 study by the Drug-Induced Liver Injury Network attributed 6 of 1091 liver-injury cases to SlimQuick, and researchers point to green tea extract as a possible cause.
The complaint is about advertising. It does not describe individual liver-injury claims. No MDL has been formed. No recall or FDA notification names SlimQuick.
Latest Slimquick Lawsuit Updates
February 17, 2026: Defendants Served in Class Action
On February 17, 2026, summonses were returned executed for Wellnx Life Sciences, Inc. and Wellnx Life Sciences DR, Inc. in the SlimQuick class action. All three named defendants have now been served.
Platinum US Distribution, Inc. had been served on February 13, 2026. No answer, motion, ruling, class certification or settlement has been entered on the court docket [1].
February 4, 2026: Class Action Filed in Federal Court
Maria Nelson and Michelle Garza filed a class action complaint with a jury demand on February 4, 2026. The defendants are Platinum US Distribution, Inc. and two Wellnx Life Sciences companies [2].
It was filed with the U.S. District Court, S.D. California, and carries the number 3:26-cv-696-GPC-BJW. The plaintiffs sued for themselves and all others similarly situated.
August 1, 2016: DILIN Study Attributes Six Liver Injury Cases to SlimQuick
Researchers in the Drug-Induced Liver Injury Network published a prospective Drug Safety study on August 1, 2016. It attributed 6 of 1091 liver-injury cases to SlimQuick products [3].
The six cases were enrolled between 2007 and 2011. The authors concluded that SlimQuick products can lead to severe acute hepatocellular liver injury, which may result in transplantation.
What Is SlimQuick?
According to LiverTox, a drug-injury database from the NIDDK, SlimQuick is a popular, proprietary line of multi-ingredient nutritional supplements. They are marketed as weight loss products. They are sold in pharmacies, grocery stores and online [4].
The major ingredients include green tea extract, caffeine and various herbal, fruit and vegetable extracts. Formulations frequently change. Wellnx Life Sciences sells the line.
Who May Be Affected?
The class action names SlimQuick Regular Strength, Extra Strength, Pure Keto and Drink Mix. The proposed class is people similarly situated to the plaintiffs, according to the Class Action Reporter [5].
In the DILIN study, six adult women aged 22 to 58 took SlimQuick for weight loss. They developed hepatitis 12 to 66 days after starting it. A legal review looks at each person’s own facts.
LiverTox says green tea hepatotoxicity typically presents with jaundice and an acute viral hepatitis-like syndrome. That syndrome improves quickly after stopping.
Reported Injuries or Damages
The complaint alleges false safety and efficacy advertising. Liver injury linked to SlimQuick comes from medical literature. LiverTox reports rare cases of clinically apparent liver injury in people taking SlimQuick.
Most had features suggestive of green tea hepatotoxicity. LiverTox also says it is difficult to implicate a specific ingredient. SlimQuick is a brand of many products with many ingredients.
A 2020 DILIN report by Hoofnagle and colleagues, as LiverTox summarises it, reviewed 1414 liver injury cases enrolled between 2004 and 2018. Forty were judged due to green tea. SlimQuick was the second most frequent commercial product, with five cases.
These findings show an association. They do not prove that SlimQuick caused any one injury. The FDA weight loss product notifications name no SlimQuick product [6].
Evidence to Preserve
Evidence helps show what you took, when you took it and what happened afterward. Keep these items:
- The SlimQuick package, bottle and lot number
- Receipts, order confirmations or bank records showing the purchase
- Photographs of the product and its label
- Medical records, liver test results and prescriptions
- A dated note of when you started and stopped taking it and when symptoms began
- Messages with the seller or maker
Store paper records and digital copies together. Keep the container, even if it is empty. These steps keep your facts clear if you later seek advice.
Filing Deadlines
Filing deadlines come from state law, and the one that applies to you depends on where you live. The timing of the exposure, illness or injury and its diagnosis also matters.
Waiting too long to file can end a claim, however strong the facts are. Check with a lawyer promptly. A lawyer can tell you which deadline applies to you and how much time remains.
Frequently Asked Questions
Is There a SlimQuick Class Action Lawsuit?
The SlimQuick class action lawsuit is assigned to Judge Gonzalo P. Curiel and Magistrate Judge Brian J. White. The plaintiffs demanded a jury trial, and the docket labels it Nature of Suit 370 Other Fraud.
What Does the Research Say About SlimQuick and Liver Injury?
The research on SlimQuick and liver injury includes a DILIN study. In it, three of the six patients were hospitalized and one had a successful liver transplant after the injury.
What Claims Does the SlimQuick Lawsuit Make About Advertising?
The SlimQuick lawsuit makes claims about advertising. It alleges the ads promise a “fat-burning” ingredient that “increases metabolism,” “reduces appetite” and “reduces excess water.” It also alleges that “made with safe and natural ingredients” and “not harmful” are false claims. These are allegations, not findings.
What Is the HLA-B*35:01 Link to SlimQuick Liver Injury?
The HLA-B*35:01 link to SlimQuick liver injury comes from the 2020 Hoofnagle report. The marker was present in 72% of green tea cases and 80% of SlimQuick cases, versus 11-15% of controls, suggesting an immunologic pathogenesis.